Most people tend to think of CRISPR as a groundbreaking gene-editing technology that can hunt down and snip away bits of DNA, like the cut and paste function on a keyboard. While many research projects tend to emphasize the potential of that process in replacing target bits of genetic material, for Mammoth Biosciences, the search […]
View More Mammoth Biosciences launches a CRISPR-powered search engine for disease detectionCategory: CRISPR
All-star team of synthetic biologists raise $53 million for cancer therapy startup Senti
A who’s-who from the world of synthetic biological research have come together to launch Senti Biosciences with $53 million in funding from a slew of venture capital investors. Led by Tim Lu, a longtime researcher at the Massachusetts Institute of Technology and one of the founding fathers of synthetic biology, Senti’s aim is nothing less than developing therapies that are tailored… Read More
View More All-star team of synthetic biologists raise $53 million for cancer therapy startup SentiWatch what it actually looks like when CRISPR snips a strand of DNA
The CRISPR-Cas9 gene-editing technique is an important concept to know about in these days of biotech advances, but it can be pretty difficult to visualize properly. Is it really like molecular scissors? Where does the DNA go? Is it a big molecul…
View More Watch what it actually looks like when CRISPR snips a strand of DNAWhile the U.S. waits, China has been CRISPRing human cancer patients since 2015
While the U.S. is just gearing up to the idea of CRISPRing its first humans, China seems to be benefiting from the “move fast and break things” — or cut them with the CRISPR scissors — motto. As The Wall Street Journal reports, China has already gene-edited 86 people using CRISPR-Cas9 since 2015. Unhindered by rules and regulations like the ones we have in America… Read More
View More While the U.S. waits, China has been CRISPRing human cancer patients since 2015Distributed applications, teams, genes and geographies will shape the future of VC in 2018
As the New Year dawns, new opportunities are emerging for savvy venture capitalists in a number of different fields. From new companies building businesses based on the genome, to businesses built on the blockchain; distributed applications, teams, genes and geographies will shape the future of the venture capital industry. 1 – A,T,G,C We are moving from a world based upon the 0s and 1s… Read More
View More Distributed applications, teams, genes and geographies will shape the future of VC in 2018The tech industry needs to move towards responsible innovation in 2018
It is incumbent for us, the technology community, to reach out to the regulators and legislators to help them better understand the wider impact of the things we’re working on. And it’s our responsibility to be transparent and honest with consumers about how we’re using their data and what they can expect from us. Read More
View More The tech industry needs to move towards responsible innovation in 2018The tech industry needs to move towards responsible innovation in 2018
It is incumbent for us, the technology community, to reach out to the regulators and legislators to help them better understand the wider impact of the things we’re working on. And it’s our responsibility to be transparent and honest with consumers about how we’re using their data and what they can expect from us. Read More
View More The tech industry needs to move towards responsible innovation in 2018